| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01013701 Details | 2017-09-13 Interventional | 4 | 7 | Fluticasone Xhance Nasal Polyps Patients With N… | Terminated based on mutual agreement between PI and sponsor (Glaxo Smith Kline) - | |||
| NCT02586961 2015-002477-38 Details | 2017-09-12 Interventional | 2/3 | 195 | Betamethasone Betamethasone V… Betamethasone b… Betamethasone s… Betamethasone-1… Epinephrine Epinephryl bora… Racepinephrine Bronchiolitis Emergencies Children | Removal of Adrénaline lots for safety reasons. - | |||
| NCT01960153 Details | 2017-09-12 Interventional | 3 | 0 | Tadalafil Heart Failure Hypertension Hypertension, P… Pulmonary Hyper… | Award was ended by NIH for parent study - | |||
| NCT01538901 Details | 2017-09-12 Interventional | 4 | 10 | Imiquimod Keratosis Keratosis, Acti… Actinic Keratos… | prolonged recruitment phase - | |||
| NCT02876081 Details | 2017-09-11 Interventional | 2 | 0 | Afatinib Adenocarcinoma Small Cell Lung… SMALL CELL LUNG… | medical decision - | |||
| NCT02222727 2013-002457-30 Details | 2017-09-11 Interventional | 2 | 19 | Donepezil Brain Ischemia Cerebral Infarc… Hemorrhage Subarachnoid He… Aneurysmal Suba… Delayed Cerebra… Delayed Neurolo… Vasospasm | CT scanner software incompatible - | |||
| NCT01894022 Details | 2017-09-11 Interventional | 3 | 19 | Ambrisentan Hypertension Hypertension, P… | - - | |||
| NCT01517984 Details | 2017-09-11 Interventional | 2 | [1 Refs] | 52 | Antilymphocyte … Calcineurin Inh… Immunosuppressi… Mycophenolic Ac… Prednisone Tacrolimus Thymoglobulin Kidney Transpla… | Absence of equipoise on the basis of predetermined stopping rules. After meeting protocol stopping rules, this trial was closed to new enrollment and randomization. No additional prespecified withdrawal of tacrolimus was allowed. Those already enrolled or randomized were followed for up to 24 months post-transplant. | ||
| NCT01416181 2010-021978-11 Details | 2017-09-11 Interventional | 3 | 889 | Natalizumab Multiple Sclero… Multiple Sclero… Neoplasm Metast… Sclerosis Secondary Progr… | The ASCEND Study did not achieve statistical significance on the primary or secondary
endpoints. - | |||
| NCT03074786 Details | 2017-09-08 Interventional | 2 | 0 | Dapivirine Emtricitabine Emtricitabine, … Tenofovir HIV-1-infection | Study was transferred to partner who will conduct under its own IND - | |||
| NCT01381549 Details | 2017-09-08 Interventional | 2 | 20 | Cilastatin Cilastatin, Imi… Imipenem Communicable Di… Infections Pyelonephritis Urinary Tract I… Infections, Uri… | Microbiological findings of resistance on therapy in patients with complicated urinary tract
infection - | |||
| NCT02677948 Details | 2017-09-06 Interventional | 1/2 | 0 | Ibrutinib Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphoma Chronic Lymphoc… Lymphoma, Small… | FDA has placed all trials involving Pacritinib on Full Clinical Hold - | |||
| NCT00857324 2008-000646-32 Details | 2017-09-06 Interventional | 1/2 | 18 | Vorinostat Multiple Myelom… Neoplasms, Plas… | The Phase I of the study was completed, but Phase 2 has not been activated - | |||
| NCT01660893 Details | 2017-09-05 Interventional | 3 | 26 | Oxymetazoline Phenylephrine Tetracaine Anesthesia | - - | |||
| NCT01310738 Details | 2017-09-05 Interventional | 4 | [1 Refs] | 378 | Amphotericin B Amphotericin B,… Deoxycholic Aci… Liposomal ampho… Meglumine Antim… Leishmaniasis Leishmaniasis, … Visceral Leishm… | DSMB recommendation based on programmed interim analysis. - | ||
| NCT03126097 Details | 2017-09-01 Interventional | 1 | 18 | Drospirenone Drospirenone an… Ethinyl Estradi… Healthy | Study stopping rules were met. - | |||
| NCT01842633 Details | 2017-09-01 Interventional | 3 | 365 | Acetaminophen Caffeine Ibuprofen Headache Pain | - Enrollment into the trial was terminated after randomization of 62% of the plan resulting in a significant reduction in study power. The originally planned inferential statistics (p-values) were therefore not presented in tables summarizing results. | |||
| NCT01217814 2010-021020-94 Details | 2017-09-01 Interventional | 2 | 16 | Folic Acid Golimumab Leucovorin Levoleucovorin Methotrexate Arthritis Arthritis, Rheu… Rheumatoid Arth… | Due to delay in the study and the impact on the development timelines, not due to any
identified safety concerns The study was prematurely terminated due to small number of participants entering randomization. | |||
| NCT03264274 2014-002003-25 Details | 2017-08-31 Interventional | 2 | 0 | Aflibercept Colorectal Neop… Colorectal Canc… | Funding restrictions - study never opened to recruitment - | |||
| NCT02512601 Details | 2017-08-31 Interventional | 4 | 13 | Glucuronyl gluc… Postphlebitic S… Postthrombotic … Syndrome Post-thrombotic… | Poor inclusion - |